Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

This test screens for 50 cancers — but whether Medicare and other health insurers will cover it hinges on FDA approval

Grail’s Galleri test looks for 50 cancers from a blood draw, but a major study failed to prove it could detect later-stage cancers.

This test screens for 50 cancers — but whether Medicare and other health insurers will cover it hinges on FDA approval

We haven't written up this one. MarketWatch has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at marketwatch.com →

More in Health & Medicine

More from Wednesday 23 September →